Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems

Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

OBJECTIVES: The purpose of this prospective single-center study was to evaluate the longer-term outcome of Palmaz-Schatz stenting in the treatment of native coronary and saphenous vein bypass graft disease. BACKGROUND: The STRESS (Stent Restenosis Study) and BENESTENT (Belgian Netherlands Stent) trials have demonstrated a decrease in both angiographic restenosis and the need for repeat revascularization in the 1st year for vessels treated by stenting rather than balloon angioplasty. Longer-term (1 to 5 years) clinical results of Palmaz-Schatz stenting are not yet well established. Late migration of the stent, metal fatigue, endarteritis and late restenosis have all been proposed as potential late clinical complications of coronary stent implantation. METHODS: The study cohort consisted of 175 consecutive patients who underwent elective placement of 194 Palmaz-Schatz stents in 185 vessels. Clinical events (death, myocardial infarction, recurrent angina or any revascularization) were assessed at 6 weeks, 2, 4 and 6 months, 1 year and yearly thereafter. Clinical follow-up was available on all patients at a mean +/- SD of 54 +/- 17 months. RESULTS: Angiographic success was achieved in 173 patients (98.9%); angiographic restenosis was observed at 6 months in 26.1% of target sites. The survival rate was 86.7% at 5 years, with a 5-year event-free survival rate decreasing progressively to 50.7%, reflecting primarily repeat revascularization procedures (41.2% at 5 years). However, the rate of repeat revascularization of the treatment site (target site revascularization [TSR]) was 14.4%, 17.7% and 19.8% at 1, 3 and 5 years, respectively, with late (> 1 year) TSR driven by in-stent restenosis in only 3 patients (1.7%). Rates of both 5-year survival (70.5% vs. 93.4%) and event-free survival (21.1% vs. 63.3%) were lower for patients who underwent saphenous vein graft (SVG) stenting than for those with native coronary artery stenting. However, 5-year TSR rates were similar for SVGs (21.9%) and native vessels (19.2%), indicating that the higher incidence of repeat revascularization for SVGs was due to an increase in non-TSR, driven by progressive disease at other sites. CONCLUSIONS: The long-term outcome of stenting shows stability of the treated lesion, with only a slight increase in TSR between 2 and 5 years (17.1% to 19.8%). The progressive increase in repeat revascularization over that period (24% to 41%) and most ongoing late events can be attributed to the progression of coronary disease at other sites, rather than to late deterioration of the stent result itself. Such non-TSR events account for the majority of clinical events in the patients who underwent SVG stenting.

This article has been cited by other articles:

				B. C. Brott Late Vascular Healing Response to Stents: New Insights From Optical Coherence Tomography J. Am. Coll. Cardiol., January 5, 2010; 55(1): 33 - 34. [Full Text] [PDF]

				J M Wilson Diagnosis and treatment of acquired coronary artery disease in adults Postgrad. Med. J., July 1, 2009; 85(1005): 364 - 365. [Abstract] [Full Text] [PDF]

				S. Yokoyama, M. Takano, M. Yamamoto, S. Inami, S. Sakai, K. Okamatsu, S. Okuni, K. Seimiya, D. Murakami, T. Ohba, et al. Extended Follow-Up by Serial Angioscopic Observation for Bare-Metal Stents in Native Coronary Arteries: From Healing Response to Atherosclerotic Transformation of Neointima Circ Cardiovasc Interv, June 1, 2009; 2(3): 205 - 212. [Abstract] [Full Text] [PDF]

				J. M. Wilson and J. T. Willerson Myocardial Revascularization with Percutaneous Devices Card. Surg. Adult, January 1, 2008; 3(2008): 573 - 598. [Full Text]

				G Sianos, A Hoye, F Saia, W van der Giessen, P Lemos, P J de Feyter, P C Levendag, R van Domburg, and P W Serruys Long term outcome after intracoronary {beta} radiation therapy Heart, July 1, 2005; 91(7): 942 - 947. [Abstract] [Full Text] [PDF]

				D. E. Cutlip, A. G. Chhabra, D. S. Baim, M. S. Chauhan, S. Marulkar, J. Massaro, A. Bakhai, D. J. Cohen, R. E. Kuntz, and K. K.L. Ho Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials Circulation, September 7, 2004; 110(10): 1226 - 1230. [Abstract] [Full Text] [PDF]

				K. Sonmez, F. Turan, M. Gencbay, M. Degertekin, and N. E. Duran Long-term (>3 Years) Clinical and Angiographic Outcomes of Coronary Multilink Stent Implantations: A Single Center Experience Angiology, September 1, 2004; 55(5): 469 - 477. [Abstract] [PDF]

				F Versaci, A Gaspardone, F Tomai, I Proietti, A S Ghini, L Altamura, G Ando, F Crea, P A Gioffre, and L Chiariello A comparison of coronary artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery: five year clinical follow up Heart, June 1, 2004; 90(6): 672 - 675. [Abstract] [Full Text] [PDF]

				D. S. Baim Percutaneous treatment of saphenous vein graft disease: The ongoing challenge J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1370 - 1372. [Full Text] [PDF]

				P. Rubartelli, E. Verna, L. Niccoli, C. Giachero, M. Zimarino, G. Bernardi, C. Vassanelli, L. Campolo, E. Martuscelli, and Gruppo Italiano di Studio sullo Stent nelle Occlus Coronary stent implantation is superior to balloon angioplasty for chronic coronary occlusions: Six-year clinical follow-up of the GISSOC trial J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1488 - 1492. [Abstract] [Full Text] [PDF]

				J. E. Sousa, M. A. Costa, A. G.M.R. Sousa, A. C. Abizaid, A. C. Seixas, A. S. Abizaid, F. Feres, L. A. Mattos, R. Falotico, J. Jaeger, et al. Two-Year Angiographic and Intravascular Ultrasound Follow-Up After Implantation of Sirolimus-Eluting Stents in Human Coronary Arteries Circulation, January 28, 2003; 107(3): 381 - 383. [Abstract] [Full Text] [PDF]

				M. E. Charlson, J. P. Allegrante, P. S. McKinley, J. C. Peterson, C. Boutin-Foster, G. Ogedegbe, and C. R. Young Improving health behaviors and outcomes after angioplasty: using economic theory to inform intervention Health Educ. Res., October 1, 2002; 17(5): 606 - 618. [Abstract] [Full Text] [PDF]

				T. Kimura, K. Abe, S. Shizuta, K. Odashiro, Y. Yoshida, K. Sakai, K. Kaitani, K. Inoue, Y. Nakagawa, H. Yokoi, et al. Long-Term Clinical and Angiographic Follow-Up After Coronary Stent Placement in Native Coronary Arteries Circulation, June 25, 2002; 105(25): 2986 - 2991. [Abstract] [Full Text] [PDF]

				E. C. Keeley, C. A. Velez, W. W. O'Neill, and R. D. Safian Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts J. Am. Coll. Cardiol., September 1, 2001; 38(3): 659 - 665. [Abstract] [Full Text] [PDF]

				S. P Schwarzacher, P. S Tsao, M. Ward, M. Hayase, J. Niebauer, J. P Cooke, and A. C Yeung Effects of stenting on adjacent vascular distensibility and neointima formation: role of nitric oxide Vascular Medicine, August 1, 2001; 6(3): 139 - 144. [Abstract] [PDF]

				F. Kiemeneij, P. W. Serruys, C. Macaya, W. Rutsch, G. Heyndrickx, P. Albertsson, J. Fajadet, V. Legrand, P. Materne, J. Belardi, et al. Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1598 - 1603. [Abstract] [Full Text] [PDF]

				E. L. Hannan, M. J. Racz, D. T. Arani, B. D. McCallister, G. Walford, and T. J. Ryan A comparison of short- and long-term outcomes for balloon angioplasty and coronary stent placement J. Am. Coll. Cardiol., August 1, 2000; 36(2): 395 - 403. [Abstract] [Full Text] [PDF]

				I. Bossi, C. Klersy, A. J. Black, R. Cortina, R. Choussat, B. Cassagneau, C. Jordan, J.-C. Laborde, J.-P. Laurent, M. Bernies, et al. In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1569 - 1576. [Abstract] [Full Text] [PDF]

				J. K. Mickelson, M. N. Ali, N. S. Kleiman, N. M. Lakkis, T. W. Chow, B. J. Hughes, and C. W. Smith Chimeric 7e3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty J. Am. Coll. Cardiol., January 1, 1999; 33(1): 97 - 106. [Abstract] [Full Text] [PDF]

				S. Elezi, A. Kastrati, J.u. Pache, A. Wehinger, M. Hadamitzky, J. Dirschinger, F.-J. Neumann, and A. Schomig Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1866 - 1873. [Abstract] [Full Text] [PDF]

				S. Kasaoka, J. M. Tobis, T. Akiyama, B. Reimers, C. Di Mario, N. D. Wong, and A. Colombo Angiographic and intravascular ultrasound predictors of in-stent restenosis J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1630 - 1635. [Abstract] [Full Text] [PDF]

				A. J. McLarty, M. R. Phillips, D. R. Holmes Jr, and H. V. Schaff Aortocoronary Bypass Grafting With Expanded Polytetrafluoroethylene: 12-Year Patency Ann. Thorac. Surg., May 1, 1998; 65(5): 1442 - 1444. [Abstract] [Full Text] [PDF]

				C. R. Narins, D. R. Holmes Jr, and E. J. Topol A Call for Provisional Stenting : The Balloon Is Back! Circulation, April 7, 1998; 97(13): 1298 - 1305. [Full Text] [PDF]